Step 1
Match the report to the vial
Confirm the sample name, batch or lot, test date and laboratory. A technically sound trace for another batch does not describe the vial in hand.
Field guide · O-026
How to read a peptide chromatogram
Read the trace before trusting the percentage. Peaks, shoulders, baselines and integration choices can reveal what a one-line purity summary leaves out.
A peptide chromatogram shows detector response over retention time; it does not directly show identity, amount or safety.
Start by matching the report to the vial and method. Then inspect the full axes, baseline, peaks, shoulders and integration boundaries. Reconcile the trace with the integration table. A clean main peak can support a purity calculation only within a suitable, validated method and detector scope.
Trace anatomy
Read the picture as a processed analytical record
The shape is useful only when the method, sample and processing choices travel with it.
Six-step check
How to inspect a peptide chromatogram
Use the same order each time so a polished graph does not distract from missing provenance or method detail.
Step 2
Read the axes and detector
Retention time runs horizontally; detector response runs vertically. Find the units, detector wavelength or detector type, and whether the page shows the full run.
Step 3
Inspect the baseline
Look for drift, noise, steps or a cropped start and finish. A weak baseline can obscure small peaks or make integration less stable.
Step 4
Count peaks and inspect shoulders
Minor peaks and shoulders may indicate additional detected components or incomplete separation. They cannot be named from shape alone.
Step 5
Check integration boundaries
See where each peak begins and ends, which features were split or combined, and whether any peaks were excluded from the percentage calculation.
Step 6
Compare trace, table and conclusion
The areas in the integration table should reconcile with the reported percentage under a stated calculation rule. Then check what the method still did not measure.
Feature by feature
What each visible feature can mean
Every feature has a defensible reading and a boundary. Shape alone rarely identifies a compound.
| Evidence object | What was measured | Defensible reading | Main limit |
|---|---|---|---|
| Retention time | When a detected component leaves the column under that method | A comparison point within a controlled method and reference system | Matching time alone does not prove molecular identity |
| Peak area | Integrated detector response over a selected boundary | Relative response when the detector and calculation are appropriate | It is not automatically mass, amount or molar percentage |
| Minor peak | Another resolved detector response | A detected component may be present | The trace alone cannot name it or show an undetected contaminant |
| Shoulder or overlap | A partly resolved feature beside a larger response | Separation or integration may need review | Shape alone cannot prove co-elution or impurity identity |
| Baseline | Detector response without a resolved peak | Noise, drift and run stability can be inspected | A clean-looking baseline does not prove method sensitivity |
Processing audit
Integration choices can change the reported percentage
Software draws boundaries around detector responses and calculates peak areas. An analyst may split overlapping peaks, use a tangent skim, combine a cluster or exclude a feature under a documented method. Those choices can be legitimate, but they should be predefined, scientifically justified and retained in the processing record.
A static image rarely shows the original data, reintegration history or excluded peaks. Ask for the integration table and processing method. If the visible trace shows a shoulder or minor peak that does not appear in the table, the laboratory should explain the rule applied.
NeededFull trace and integration table
NeededMethod and detector
NeededSample and batch match
NeededProcessing history
Method boundary
What a chromatogram cannot prove
A result cannot establish an attribute the method did not measure. Even a well-run HPLC purity method leaves other questions open.
- Retention time alone does not establish molecular identity.
- Relative peak area does not automatically establish the amount of peptide in the vial.
- One detector may miss components that respond weakly or not at all under its settings.
- A resolved main peak can still contain co-eluting material unless specificity has been demonstrated.
- Chromatographic purity does not establish sterility, endotoxin control or absence of every contaminant.
- A result describes the submitted sample, not every vial or the full supply chain.
- No chromatogram establishes clinical effectiveness or safe use.
Request the record
What should accompany the chromatogram
A useful record lets another competent reader understand what was tested, how it was processed and whether the conclusion follows.
Provenance
Sample, batch and laboratory
Look for the sample identifier, batch or lot, receipt and test dates, issuing laboratory and a direct verification route.
Method
Column, mobile phase and detector
The method should identify operating conditions, detector wavelength or type, reference material, run length and system suitability.
Processing
Integration table and audit trail
Ask for peak retention times, areas, area percentages, excluded features and documented reasons for manual reintegration.
Technical ledger
Guidance behind the checklist
These sources define method suitability, specificity, integration and data-integrity limits. They do not validate a certificate by appearance.
| Source | What it establishes | What it does not establish | Checked |
|---|---|---|---|
| ICH Q2(R2) via FDA | Analytical procedures must be validated as suitable for their intended purpose, including specificity and performance. | The guidance does not validate a vendor's method or interpret a cropped image. | 9 Aug 2026 |
| ICH M10 bioanalytical guidance | Integration and reintegration rules should be predefined, documented and retained with original results. | Bioanalytical guidance is not a batch-specific peptide purity verdict. | 9 Aug 2026 |
| FDA analytical validation guidance | Peak-purity or orthogonal approaches may be needed to assess whether one peak contains more than one component. | A peak-purity test does not prove every identity, quantity or safety attribute. | 9 Aug 2026 |
| FDA data-integrity guidance | Chromatographic processing changes and source data must be preserved and attributable. | A screenshot alone cannot reveal the complete audit trail. | 9 Aug 2026 |
| FDA chromatogram integration manual | Shows how split peaks, tangent skims and excluded peaks can change integrated areas. | Food-laboratory examples do not validate a peptide method; they illustrate processing choices. | 9 Aug 2026 |
Continue the check
Put the trace back into the certificate
- the purity figure this producesSee how area percentages are calculated and why detector response is not automatically mass percentage.
- what the test cannot proveMatch identity, purity, quantity, sterility and contaminants to separate analytical questions.
- when the trace contradicts the summaryCheck missing peaks, reused reports, unmatched batches and laboratory verification routes.
- back to the testing hubReturn to the full certificate and laboratory-checking sequence.
Quick answers
Frequently asked questions
What do the axes on a chromatogram show?
The horizontal axis usually shows retention time. The vertical axis shows detector response. Check the method because units and detector type determine what the trace means.
Does the tallest peak identify the peptide?
No. A tall peak shows a strong detector response at a retention time. Identity needs a suitable reference or orthogonal method such as mass spectrometry.
What is a shoulder peak?
A shoulder is a partly resolved feature attached to a larger peak. It may signal co-elution, but the raw data and method are needed before assigning it.
Can I recalculate purity from a chromatogram image?
Usually not reliably. You need the integration table, processing method, detector settings and rules for excluded peaks. An image may be cropped or rescaled.
Does 99 percent HPLC purity mean the vial is safe?
No. Chromatographic area percentage does not establish identity, amount, sterility, endotoxin, every contaminant or clinical safety.
What should I ask for with the trace?
Ask for the method, detector, sample and batch identifiers, full integration table, system-suitability results, processing history and a route to verify the report with the laboratory.
Editorial experience
From our work: how we checked this page
For topical-map item O-026, How to read a peptide chromatogram was checked as a distinct editorial task, not treated as a generic peptide page. We reviewed 5 unique external sources and 6 internal destinations in the page, then checked that the opening answer, headings, source descriptions and linked next steps stayed within the same claim boundary. The count records links in the published page and is not a claim that every source carries equal evidential weight.
Eleni Kiromitis checked the laboratory and scientific wording, drawing on direct experience commissioning laboratory tests and reviewing certificates of analysis and chromatograms. She checked whether each method was matched to the attribute it can measure, whether sample and batch limits remained visible, and whether the conclusion stopped where the analytical record stopped. Yianni Kiromitis retained responsibility for source verification, editorial decisions and correction management.
We did not use patient experience, a personal treatment outcome, seller testimony or an assumed product identity to support this page. The publication did not independently test a vial for this review. Where a page refers to a laboratory result, that result applies only to the named sample, method and attribute. We kept uncertainty beside the conclusion, recorded which source supports each material claim, and checked that the visible review date matches the publication record. A new controlled study, regulator update, corrected source, analytical report or credible safety signal can trigger reassessment through the public correction route.